China Kangtai Cactus Bio-tech Inc. (OTCBB:CKGT), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based products in China, announces that it recently initiated business negotiations with Taiwan Tong He Mai Bio-tech Inc, a well-known health care products manufacturer in Taiwan. The two companies discussed the potential cooperation in the R&D, manufacturing, and marketing arenas.

Established in June 2002, Taiwan Tong He Mai Bio-tech Inc. generates a significant market profit through the integration of the research, manufacturing, and marketing of polysaccharides series products. These high-quality compound polysaccharide products are created by utilizing such ingredients as lucid ganoderma, antrodiacinnamomea, cordyceps sinensis, agaricus blazei, schizophyllan, and sparasis crispa.

As a final result of the negotiations, Taiwan Tong He Mai plans to add China Kangtai's cactus component into its original series products in order to enhance their current products' benefits such as boosting immunity and the excretion of toxins for an overall quality of life improvement.

?We are very pleased to have initiated these significant business negotiations with China Kangtai, a company with an absolute advantageous posture in China mainland's cactus industry,? said Hongzhen Zhang, Chief Manager of Taiwan Tong He Mai. ?The potential cooperation has a meaningful concept that encompasses product structure, functions, producing technology, and future marketing of health care products which is a significant development for both companies.?

?Through our deep negotiations, the mutual understanding and trust is strengthened, aiding in the establishment of a conceptual framework for future cooperation? said Jinjiang Wang, the President of China Kangtai. ?China Kangtai will diligently cooperate with Taiwan Tong He Mai in the improvement of the technological content of our health care products, thereby, adding a value-added component to our products, as well as, providing an expansion of marketing channels in Taiwan and the surrounding countries.?

About China Kangtai Cactus Bio-tech, Inc.

China Kangtai Cactus Bio-tech, Inc. is a leading grower, developer, producer, and marketer of cactus-derived products, including nutraceuticals, nutritious food, health and energy drinks, beer, wine and liquor, extracts and powders, and animal feed. China Kangtai controls over 387 acres of plants and maintains an active R&D group that holds 18 product patents and is seeking another 12. China Kangtai's high-quality ?green? products are sold throughout China via a distribution network that covers 12 of China's 23 provinces and two of China's four municipalities. More information may be found at http://www.biocactus.com or via e-mail: chinakangtai@gmail.com.

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

Investor Relations:
Equiti-trend Advisors
Brian Barnes
858-436-3350 or 800-953-3350